Cargando…
Comparison of Incidence of Myocardial Infarction in Patients With Rheumatoid Arthritis and Diabetes Mellitus
Introduction Patients with rheumatoid arthritis (RA) have a higher risk of cardiovascular diseases (CVDs) when compared to the general population, with most deaths attributed to myocardial infarctions (MI). However, patients with RA do not get the same attention in terms of cardiovascular screening...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290906/ https://www.ncbi.nlm.nih.gov/pubmed/34295575 http://dx.doi.org/10.7759/cureus.15716 |
_version_ | 1783724547004956672 |
---|---|
author | Ali, Azka Ali, Akhtar Kumar, Dilpat Kumar, Ravi Elahi, Kanwal Suman, FNU Anjum, Zauraiz Tharwani, Payal Jahangir, Maha Rizwan, Amber |
author_facet | Ali, Azka Ali, Akhtar Kumar, Dilpat Kumar, Ravi Elahi, Kanwal Suman, FNU Anjum, Zauraiz Tharwani, Payal Jahangir, Maha Rizwan, Amber |
author_sort | Ali, Azka |
collection | PubMed |
description | Introduction Patients with rheumatoid arthritis (RA) have a higher risk of cardiovascular diseases (CVDs) when compared to the general population, with most deaths attributed to myocardial infarctions (MI). However, patients with RA do not get the same attention in terms of cardiovascular screening as compared to other diseases, like diabetes mellitus (DM). Therefore, this study aims to compare the risk of CVD among patients with RA and DM. Methods This prospective study was carried out in Pakistan’s two tertiary care hospitals. A total of 750 participants were enrolled in three groups with a 1:1:1 ratio; patients with RA, type 2 DM, and the control group. Patients were observed for 12 months or until the development of a major adverse cardiovascular event (MACE), whichever occurred first. Results Both fatal (12.66% vs. 13.48%; p-value: 0.79) and non-fatal (3.93% vs. 4.35%; p-value: 0.82) MI was comparable between both RA and DM group. However, compared to the control group, non-fatal MI (12.66% vs. 5.58%; p-value: 0.01) was significantly higher in the RA group. Conclusion Our study shows that RA and DM have an equal risk of cardiovascular (CV) events. It is important that RA should be considered as a prominent risk factor for CV events. The management of these patients should be multidisciplinary, including cardiologists. |
format | Online Article Text |
id | pubmed-8290906 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-82909062021-07-21 Comparison of Incidence of Myocardial Infarction in Patients With Rheumatoid Arthritis and Diabetes Mellitus Ali, Azka Ali, Akhtar Kumar, Dilpat Kumar, Ravi Elahi, Kanwal Suman, FNU Anjum, Zauraiz Tharwani, Payal Jahangir, Maha Rizwan, Amber Cureus Cardiology Introduction Patients with rheumatoid arthritis (RA) have a higher risk of cardiovascular diseases (CVDs) when compared to the general population, with most deaths attributed to myocardial infarctions (MI). However, patients with RA do not get the same attention in terms of cardiovascular screening as compared to other diseases, like diabetes mellitus (DM). Therefore, this study aims to compare the risk of CVD among patients with RA and DM. Methods This prospective study was carried out in Pakistan’s two tertiary care hospitals. A total of 750 participants were enrolled in three groups with a 1:1:1 ratio; patients with RA, type 2 DM, and the control group. Patients were observed for 12 months or until the development of a major adverse cardiovascular event (MACE), whichever occurred first. Results Both fatal (12.66% vs. 13.48%; p-value: 0.79) and non-fatal (3.93% vs. 4.35%; p-value: 0.82) MI was comparable between both RA and DM group. However, compared to the control group, non-fatal MI (12.66% vs. 5.58%; p-value: 0.01) was significantly higher in the RA group. Conclusion Our study shows that RA and DM have an equal risk of cardiovascular (CV) events. It is important that RA should be considered as a prominent risk factor for CV events. The management of these patients should be multidisciplinary, including cardiologists. Cureus 2021-06-17 /pmc/articles/PMC8290906/ /pubmed/34295575 http://dx.doi.org/10.7759/cureus.15716 Text en Copyright © 2021, Ali et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Cardiology Ali, Azka Ali, Akhtar Kumar, Dilpat Kumar, Ravi Elahi, Kanwal Suman, FNU Anjum, Zauraiz Tharwani, Payal Jahangir, Maha Rizwan, Amber Comparison of Incidence of Myocardial Infarction in Patients With Rheumatoid Arthritis and Diabetes Mellitus |
title | Comparison of Incidence of Myocardial Infarction in Patients With Rheumatoid Arthritis and Diabetes Mellitus |
title_full | Comparison of Incidence of Myocardial Infarction in Patients With Rheumatoid Arthritis and Diabetes Mellitus |
title_fullStr | Comparison of Incidence of Myocardial Infarction in Patients With Rheumatoid Arthritis and Diabetes Mellitus |
title_full_unstemmed | Comparison of Incidence of Myocardial Infarction in Patients With Rheumatoid Arthritis and Diabetes Mellitus |
title_short | Comparison of Incidence of Myocardial Infarction in Patients With Rheumatoid Arthritis and Diabetes Mellitus |
title_sort | comparison of incidence of myocardial infarction in patients with rheumatoid arthritis and diabetes mellitus |
topic | Cardiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290906/ https://www.ncbi.nlm.nih.gov/pubmed/34295575 http://dx.doi.org/10.7759/cureus.15716 |
work_keys_str_mv | AT aliazka comparisonofincidenceofmyocardialinfarctioninpatientswithrheumatoidarthritisanddiabetesmellitus AT aliakhtar comparisonofincidenceofmyocardialinfarctioninpatientswithrheumatoidarthritisanddiabetesmellitus AT kumardilpat comparisonofincidenceofmyocardialinfarctioninpatientswithrheumatoidarthritisanddiabetesmellitus AT kumarravi comparisonofincidenceofmyocardialinfarctioninpatientswithrheumatoidarthritisanddiabetesmellitus AT elahikanwal comparisonofincidenceofmyocardialinfarctioninpatientswithrheumatoidarthritisanddiabetesmellitus AT sumanfnu comparisonofincidenceofmyocardialinfarctioninpatientswithrheumatoidarthritisanddiabetesmellitus AT anjumzauraiz comparisonofincidenceofmyocardialinfarctioninpatientswithrheumatoidarthritisanddiabetesmellitus AT tharwanipayal comparisonofincidenceofmyocardialinfarctioninpatientswithrheumatoidarthritisanddiabetesmellitus AT jahangirmaha comparisonofincidenceofmyocardialinfarctioninpatientswithrheumatoidarthritisanddiabetesmellitus AT rizwanamber comparisonofincidenceofmyocardialinfarctioninpatientswithrheumatoidarthritisanddiabetesmellitus |